Clinical trials
Injection clinical trials
Below are recruiting injection clinical trials, each written for real people, not researchers. We’re tracking 2,040 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04220931Recruiting
Botox shot to help prevent a pancreas leak after distal surgery
This trial studies whether injecting a Botox-like medicine into the pancreatic drainage area can help prevent a post-surgery pancreas fistula (a persistent leak). It’s for adults having a planned distal pancreatectomy, and it may help reduce complications after surgery.
ClichyAges 18 years+ - NCT05961644RecruitingPhase 2/Phase 3
Cladribine vs placebo for non-active progressive multiple sclerosis
This trial tests whether cladribine (vs an inactive placebo pill) can slow disability worsening in people with a non-active, progressive form of multiple sclerosis. It may help by reducing the immune activity that can drive ongoing nerve damage, even without recent relapses.
Warsaw, Masovian VoivodeshipAges 30–65 - NCT06045091RecruitingEarly Phase 1
BCMA-targeted CAR-NK cells for multiple myeloma or plasma cell leukemia
This trial tests an experimental therapy using immune cells (CAR-NK cells) designed to target and kill cancer cells in people with multiple myeloma or plasma cell leukemia that has returned or stopped responding to treatment. The goal is to see if it is safe and effective.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT02013336RecruitingPhase 1
Two-drug study for returning childhood solid tumors
This study tests a combination of two drugs, MM-398 and cyclophosphamide, for children and young adults whose cancer has come back or not responded to earlier treatment. The goal is to find the best dose and see how well it works against certain tumor types.
Cincinnati, OhioAges 1–20 - NCT05492123RecruitingPhase 2
Nivolumab plus ipilimumab with chemoradiation for cervical cancer
This Phase 2 study tests whether adding immunotherapy (nivolumab and ipilimumab) to standard chemoradiation can improve treatment for cervical cancer. It may help by training the immune system to better target cancer cells while radiation and chemotherapy work in the body.
Fortaleza, CearáAges 18–95 - NCT06058078RecruitingPhase 2
Cell therapy for active lupus nephritis
This trial tests a new cell therapy (RY_SW01) for people with active lupus nephritis (kidney inflammation caused by lupus) who haven't responded well to standard treatments. It aims to see if the therapy can help control the disease.
Nanjing, JiangsuAges 18–65 - NCT06058091RecruitingPhase 1/Phase 2
Cell injection therapy for systemic sclerosis
This trial tests a new cell injection treatment (RY_SW01) for people with systemic sclerosis (a condition causing skin thickening and organ issues). It aims to see if the therapy can improve skin hardening and overall symptoms.
Nanjing, JiangsuAges 18–65 - NCT05746897RecruitingPhase 1
First-in-human test of an anti-PVRIG drug for advanced cancers
This early-phase study tests NM1F (an anti-PVRIG antibody) in people with advanced solid tumors to see if it’s safe and whether it may work. It also includes pembrolizumab (a PD-1 “checkpoint” medicine), aiming to boost the immune system against the cancer.
Dallas, TexasAges 18 years+ - NCT05952947RecruitingPhase 1
Study drug for HPV18-positive solid tumors with a specific immune marker
This Phase 1 trial tests HRYZ-T101 injection for people whose solid cancer is HPV18-positive and who have the HLA-DRB1*0901 immune marker. It is meant for people whose cancer has returned or spread and who have few or no effective treatment options.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07867353Recruiting
Long-term effects of permanent fillers in the buttocks
This study looks at people who had permanent (non-dissolving) fillers injected into their buttocks, to better understand the health problems these fillers can cause over time. If you've had such fillers and are having symptoms, joining helps doctors learn more about your condition and improve future care.
Medellín, AntioquiaAges 18 years+ - NCT07871825RecruitingPhase 4
Study of G-CSF for diminished ovarian reserve in IVF
This study tests a medicine called G-CSF (given as an injection) to see if it helps improve egg quality and IVF success in women with a lower egg supply (diminished ovarian reserve). If you are between 35 and 44 and have been told your egg count is low but not too low, this might be worth exploring.
New York, New YorkAges 35–44 - NCT07872553RecruitingEarly Phase 1
Kidney cancer treatment preference study
This study looks at how kidney cancer patients feel about getting their treatment at home versus at the clinic, and asks their doctors for their views too. It is for patients already on certain standard treatments and aims to understand preferences that may improve care.
Basking Ridge, New JerseyAges 18 years+ - NCT06279026Recruiting
Testing UTAA17 for advanced multiple myeloma
This trial tests a new treatment called UTAA17 that targets a protein on myeloma cells. It may be an option for people whose multiple myeloma has not responded to several prior treatments.
Suzhou, JiangsuAges 18 years+ - NCT07868913RecruitingPhase 2
Ketamine and talk therapy for suicidal thoughts in the ER
This study tests whether a single dose of ketamine, given together with a brief talk therapy session, can quickly reduce suicidal thoughts in people arriving at the emergency department. The goal is to see if this combination can help people feel safer sooner before they move to inpatient care.
Fort Hood, TexasAges 18–70 - NCT07869511Recruiting
Steroid injection behind the eye for light-damage to the retina
This study tests whether a steroid injection behind the eye (a retrobulbar injection) can help people whose retina (the light-sensing layer at the back of the eye) has been damaged by looking at a strong light source, like a laser or bright flash. The treatment aims to reduce swelling and vision problems that can follow such an injury.
Hangzhou, ZhejiangAges 6 years+ - NCT07867080RecruitingPhase 3
Gene therapy injection for diabetic macular edema
This trial tests a one-time gene therapy injection into the eye for adults with diabetic macular edema (DME), a condition where fluid builds up in the retina and blurs vision. The goal is to reduce the need for frequent eye injections and help maintain vision over time.
Scottsdale, ArizonaAges 18 years+ - NCT04396223RecruitingPhase 1/Phase 2
Avelumab plus methotrexate for low-risk gestational tumor
This study tests whether avelumab (an immune therapy) combined with methotrexate (chemotherapy) can work well as the first treatment for low-risk gestational trophoblastic neoplasia. It aims to improve control of the tumor while keeping side effects acceptable.
Pierre-Bénite, Pierre BéniteAges 18 years+ - NCT06227117RecruitingPhase 2
Study of DV and Toripalimab before surgery for HER2-low breast cancer
This trial tests a combination of two drugs (DV and Toripalimab) with chemotherapy before surgery for a specific type of breast cancer (HER2-low, HR-negative) that has not spread too far. The goal is to see if this approach can shrink the tumor and improve outcomes.
Changsha, HunanAges 18 years+ - NCT05877924RecruitingPhase 1
Early-phase study of an injected cancer treatment for advanced tumors
This Phase 1 trial tests NBL-020, an injected medicine, in adults with advanced solid cancers (and possibly some skin T-cell lymphoma) to see how it works and how safe it is. You may be considered if standard treatment has stopped working or isn’t tolerated and if you can provide recent tumor tissue for lab testing.
Guanzhou, GuangdongAges 18 years+ - NCT06343077RecruitingPhase 2
Hiltonol injection for prostate cancer on active surveillance
This trial tests a drug called Hiltonol (Poly-ICLC) given directly into the prostate tumor along with an injection under the skin. It is for men with low-risk prostate cancer who are on active surveillance, to see if the drug can slow or stop the cancer from growing.
New York, New YorkAges 18 years+ - NCT06342336RecruitingPhase 1
HS-IT101 injection for advanced solid tumors
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
Beijing, Beijing MunicipalityAges 3 weeks–2 months - NCT06361485RecruitingPhase 1
Umbilical cord injection for chronic low back pain
This study tests whether a special injection made from umbilical cord tissue is safe and can help with long-term low back pain. It is for adults who have not had recent back procedures or certain health problems.
Scottsdale, ArizonaAges 20 years+ - NCT06300177RecruitingPhase 3
New targeted pill vs. chemotherapy for KRAS G12C lung cancer
This trial compares a new targeted pill (D-1553) against a standard chemotherapy (docetaxel) for people with a specific type of advanced lung cancer (KRAS G12C mutation) whose cancer has stopped responding to first-line immunotherapy and chemotherapy.
Hefei, AnhuiAges 18 years+ - NCT06358807Recruiting
Microfracture with PRP gel for ankle cartilage injury
This trial tests a surgery called microfracture (making tiny holes in the bone to help new cartilage grow) combined with a gel made from your own platelet-rich plasma (PRP) to treat a small ankle cartilage injury. The goal is to see if adding PRP gel improves healing and reduces pain.
BeijingAges 18–60
Hear when a new Injection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for injection?
- Yes. Clin2 currently lists 2,040 recruiting injection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a injection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a injection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.